BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15217397)

  • 1. Selective antagonism of medial prefrontal cortex D4 receptors decreases fear-related behaviour in rats.
    Shah AA; Sjovold T; Treit D
    Eur J Neurosci; 2004 Jun; 19(12):3393-7. PubMed ID: 15217397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the medial prefrontal cortex with the GABAA receptor agonist muscimol increases open-arm activity in the elevated plus-maze and attenuates shock-probe burying in rats.
    Shah AA; Sjovold T; Treit D
    Brain Res; 2004 Nov; 1028(1):112-5. PubMed ID: 15518648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptors in the medial prefrontal cortex and hippocampus mediate rats' unconditioned fear behaviour.
    McEown K; Treit D
    Horm Behav; 2011 Nov; 60(5):581-8. PubMed ID: 21889941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prefrontal dopamine D4 receptors are involved in encoding fear extinction.
    Pfeiffer UJ; Fendt M
    Neuroreport; 2006 May; 17(8):847-50. PubMed ID: 16708027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-medial prefrontal administration of SCH-23390 attenuates ERK phosphorylation and long-term memory for trace fear conditioning in rats.
    Runyan JD; Dash PK
    Neurobiol Learn Mem; 2004 Sep; 82(2):65-70. PubMed ID: 15341790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infusions of midazolam into the medial prefrontal cortex produce anxiolytic effects in the elevated plus-maze and shock-probe burying tests.
    Shah AA; Treit D
    Brain Res; 2004 Jan; 996(1):31-40. PubMed ID: 14670628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of morphine on rat behaviour in the elevated plus maze: the role of central amygdala dopamine receptors.
    Rezayof A; Hosseini SS; Zarrindast MR
    Behav Brain Res; 2009 Sep; 202(2):171-8. PubMed ID: 19463698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory.
    Wall PM; Messier C
    Psychopharmacology (Berl); 2002 Mar; 160(3):233-44. PubMed ID: 11889492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microinjections of the dopamine D2 receptor antagonist sulpiride into the medial prefrontal cortex attenuate glucocorticoid-induced impairment of long-term memory retrieval in rats.
    Pakdel R; Rashidy-Pour A
    Neurobiol Learn Mem; 2007 Mar; 87(3):385-90. PubMed ID: 17118678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of medial prefrontal cortex lesions on anxiety-like behaviour in restrained and non-restrained rats.
    Blanco E; Castilla-Ortega E; Miranda R; Begega A; Aguirre JA; Arias JL; Santín LJ
    Behav Brain Res; 2009 Aug; 201(2):338-42. PubMed ID: 19428654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D1 dopamine and NMDA receptors interactions in the medial prefrontal cortex: modulation of spatial working memory in rats.
    Rios Valentim SJ; Gontijo AV; Peres MD; Rodrigues LC; Nakamura-Palacios EM
    Behav Brain Res; 2009 Dec; 204(1):124-8. PubMed ID: 19482047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of the medial prefrontal cortex and amygdala underlies one-trial tolerance of rats in the elevated plus-maze.
    Albrechet-Souza L; Borelli KG; Brandão ML
    J Neurosci Methods; 2008 Mar; 169(1):109-18. PubMed ID: 18190969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of type 4 dopaminergic receptors in the prelimbic area of medial prefrontal cortex is necessary for the expression of innate fear behavior.
    Vergara MD; Keller VN; Fuentealba JA; Gysling K
    Behav Brain Res; 2017 May; 324():130-137. PubMed ID: 28212942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus.
    Engin E; Treit D
    Behav Pharmacol; 2007 Sep; 18(5-6):461-70. PubMed ID: 17762514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent effects of prefrontal dopamine on behavioral state in rats.
    Dent MF; Neill DB
    Behav Neurosci; 2012 Oct; 126(5):620-39. PubMed ID: 22925081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of dopamine D(2)-like receptors in the rat amygdala and their role in the modulation of unconditioned fear and anxiety.
    Perez de la Mora M; Gallegos-Cari A; Crespo-Ramirez M; Marcellino D; Hansson AC; Fuxe K
    Neuroscience; 2012 Jan; 201():252-66. PubMed ID: 22100273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medial prefrontal cortex infusions of bupivacaine or AP-5 block extinction of amphetamine conditioned place preference.
    Hsu E; Packard MG
    Neurobiol Learn Mem; 2008 May; 89(4):504-12. PubMed ID: 17905604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
    Mendes-Gomes J; Nunes-de-Souza RL
    Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of D1 but not D2 receptors in methamphetamine-induced impairment of long-term potentiation in hippocampal-prefrontal cortex pathway.
    Ishikawa A; Kadota T; Kadota K; Matsumura H; Nakamura S
    Eur J Neurosci; 2005 Oct; 22(7):1713-9. PubMed ID: 16197511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.